During the past decade, City Hospital #15 conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "City Hospital #15" #1 sponsor was "Ferring Pharmaceuticals" with 4 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Bayer" with 2 trials sponsored, "Allena Pharmaceuticals" with 1 trials sponsored and "Bavarian Nordic" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "City Hospital #15" #1 collaborator was "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator, "OCT Clinical Trials" with 1 trials as a collaborator and "argenx" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "City Hospital #15" are "Prostate Cancer" (4 trials), "Myelodysplastic Syndromes" (2 trials), "Anemia" (1 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials) and "Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "City Hospital #15" in a lesser frequency.

Most popular intervention types in "City Hospital #15" are "Drug" (14 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Degarelix" (3 trials), "Azacitidine" (1 trials), "Cusatuzumab" (1 trials) and "Dara IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "City Hospital #15" are 9 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "City Hospital #15". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in City Hospital #15, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in City Hospital #15, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".